These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3276930)

  • 1. Effect of chronic nitrofurantoin on the rabbit urinary bladder.
    Levin RM; Lavkar RM; Monson FC; Witowski BA; Wein AJ; Hanno PM; Ruggieri MR
    J Urol; 1988 Feb; 139(2):400-4. PubMed ID: 3276930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrofurantoin not surface active agent in rabbit urinary bladder.
    Ruggieri MR; Hanno PM; Levin RM
    Urology; 1987 May; 29(5):534-7. PubMed ID: 3576874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of the bladder mucosa.
    Schlager TA; Lohr JA; Hendley JO
    Urol Res; 1993; 21(5):313-7. PubMed ID: 8279086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of heparin on the adherence of five species of urinary tract pathogens to urinary bladder mucosa.
    Ruggieri MR; Hanno PM; Levin RM
    Urol Res; 1984; 12(4):199-203. PubMed ID: 6437032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of bovine bladder mucin fractions that inhibit Escherichia coli adherence to the mucin deficient rabbit bladder.
    Ruggieri MR; Balagani RK; Rajter JJ; Hanno PM
    J Urol; 1992 Jul; 148(1):173-8. PubMed ID: 1613864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial effects of nitric oxide on uropathogenic Escherichia coli during bladder epithelial cell colonization--a comparison with nitrofurantoin.
    Vumma R; Bang CS; Kruse R; Johansson K; Persson K
    J Antibiot (Tokyo); 2016 Mar; 69(3):183-6. PubMed ID: 26531685
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of bacillus Calmette-Guerin attachment to the urothelium by removal of the rabbit bladder mucin layer.
    Badalament RA; Franklin GL; Page CM; Dasani BM; Wientjes MG; Drago JR
    J Urol; 1992 Feb; 147(2):482-5. PubMed ID: 1732628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further characterization of bacterial adherence to urinary bladder mucosa: comparison with adherence to anion exchange resin.
    Ruggieri MR; Hanno PM; Levin RM
    J Urol; 1985 Nov; 134(5):1019-23. PubMed ID: 3932676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on infectious mechanism of type 1 fimbriated Escherichia coli in experimental cystitis of mice].
    Jie L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):250-4. PubMed ID: 7909502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective antiadherence activity of bladder extracts from patients with recurrent urinary tract infection.
    Ruggieri MR; Levin RM; Hanno PM; Witkowski BA; Gill HS; Steinhardt GF
    J Urol; 1988 Jul; 140(1):157-9. PubMed ID: 3379683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
    Wang X; Liu W; O'Donnell M; Lutgendorf S; Bradley C; Schrepf A; Liu L; Kreder K; Luo Y
    PLoS One; 2016; 11(12):e0168772. PubMed ID: 28002455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of intravesical furadantin instillations on experimental E. coli infection of the urinary bladder].
    Prát V; Konícková L; Hatala M; Urbanová D
    Z Urol Nephrol; 1967 May; 60(5):305-10. PubMed ID: 4872289
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible inactivation of bladder surface glycosaminoglycan antibacterial activity by protamine sulfate.
    Parsons CL; Stauffer CW; Schmidt JD
    Infect Immun; 1988 May; 56(5):1341-3. PubMed ID: 3281908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of the difference in bacterial adherence between bladder and ileum using rat ileal augmented bladder.
    Nakano Y; Fujisawa M; Matsui T; Arakawa S; Kamidono S
    J Urol; 1999 Jul; 162(1):243-7. PubMed ID: 10379794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.
    Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():34-41. PubMed ID: 24807491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli adherence to anion exchange resin. In vitro model for initial screening of potential antiadherence agents.
    Ruggieri MR; Hanno PM; Levin RM
    Urology; 1986 Apr; 27(4):343-8. PubMed ID: 3083556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental pyelonephritis and cystitis as models in evaluating chemotherapeutic drugs].
    Degen L; Salvaterra M
    Boll Chim Farm; 1967 Aug; 106(8):534-40. PubMed ID: 5613335
    [No Abstract]   [Full Text] [Related]  

  • 18. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
    J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of soluble virulence factor by Escherichia coli.
    Mostafavi M; Stein PC; Parsons CL
    J Urol; 1995 May; 153(5):1441-3. PubMed ID: 7714961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of nitrofurantoin for the treatment of nosocomial catheter-associated bacteriuria (CAB) and cystitis.
    Cunha BA; Lee P; Kaouris N; Raza M
    J Chemother; 2015 Feb; 27(2):122-3. PubMed ID: 25004793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.